We are live on !
Find out more
Xponance Portfolio holdings
AUM
$16.3B
Turnover
12.69%
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter Est. Return
+29.51%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$16.3B
AUM Growth
+$2.23B
(+16%)
Cap. Flow
-$15.3M
Cap. Flow % of AUM
Cap. Flow %
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
37.34%
Holding
1,883
New
197
Increased
1,009
Reduced
634
Closed
42
Avg Time Held
3.4
years
Top 10 Avg Time Held
4.7
years
Top 20 Avg Time Held
3.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$80.6M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$76.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$57.8M |
| 4 |
Caterpillar
CAT
|
+$32.2M |
| 5 |
Applied Materials
AMAT
|
+$26.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$149M |
| 2 |
Amazon
AMZN
|
+$128M |
| 3 |
Microsoft
MSFT
|
+$121M |
| 4 |
AbbVie
ABBV
|
+$34.6M |
| 5 |
Costco
COST
|
+$25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.2% |
| 2 | Communication Services | 10.83% |
| 3 | Financials | 10.29% |
| 4 | Consumer Discretionary | 9.28% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
Sable Offshore Corp
SOC
$612M
| $39.5K | ﹤0.01% |
12,837
+1,513
| +13% | +$19.3K |
2026 Q1
1 quarter
|
|
1802
Ovid Therapeutics
OVID
$428M
| $39.2K | ﹤0.01% |
+14,560
| New | +$37.6K |
2026 Q2
0 quarters
|
|
1803
Richtech Robotics
RR
$284M
| $37.9K | ﹤0.01% |
17,962
+3,095
| +21% | +$7.52K |
2025 Q4
2 quarters
|
|
1804
Optimum Communications Inc
OPTU
$348M
| $37.2K | ﹤0.01% |
25,678
+2,109
| +9% | +$2.62K |
2025 Q2
4 quarters
|
|
1805
FerroAtlántica
GSM
$787M
| $36.7K | ﹤0.01% |
11,554
+895
| +8% | +$3.7K |
2026 Q1
1 quarter
|
|
1806
Xerox
XRX
$326M
| $36.4K | ﹤0.01% |
11,618
+1,040
| +10% | +$2.6K |
2026 Q1
1 quarter
|
|
1807
American Battery Technology Co
ABAT
$205M
| $34.9K | ﹤0.01% |
12,328
+1,453
| +13% | +$4.65K |
2026 Q1
1 quarter
|
|
1808
Gevo
GEVO
$282M
| $34.1K | ﹤0.01% |
22,762
+2,161
| +10% | +$3.81K |
2025 Q2
4 quarters
|
|
1809
Cabaletta Bio
CABA
$253M
| $33.3K | ﹤0.01% |
+10,707
| New | +$35.2K |
2026 Q2
0 quarters
|
|
1810
Clean Energy Fuels
CLNE
$313M
| $31K | ﹤0.01% |
15,133
-489
| -3% | -$1.04K |
2023 Q3
11 quarters
|
|
1811
Hertz
HTZ
$659M
| $30K | ﹤0.01% |
13,238
+1,557
| +13% | +$8.5K |
2025 Q1
5 quarters
|
|
1812
Palisade Bio
PALI
$234M
| $29.4K | ﹤0.01% |
+14,066
| New | +$27.7K |
2026 Q2
0 quarters
|
|
1813
Blend Labs
BLND
$235M
| $29.3K | ﹤0.01% |
17,160
-960
| -5% | -$1.53K |
2024 Q2
8 quarters
|
|
1814
Century Therapeutics
IPSC
$270M
| $28.8K | ﹤0.01% |
+11,769
| New | +$26.9K |
2026 Q2
0 quarters
|
|
1815
DELISTED
Olaplex Holdings
OLPX
| $28.4K | ﹤0.01% |
13,838
+1,034
| +8% | +$2.11K |
2025 Q2
4 quarters
|
|
1816
Akebia Therapeutics
AKBA
$188M
| $28.1K | ﹤0.01% |
24,606
+1,824
| +8% | +$2.17K |
2024 Q2
8 quarters
|
|
1817
Eve Holding
EVEX
$561M
| $27.9K | ﹤0.01% |
+11,100
| New | +$32K |
2026 Q2
0 quarters
|
|
1818
Compass Therapeutics
CMPX
$151M
| $27.5K | ﹤0.01% |
12,550
+714
| +6% | +$2.11K |
2025 Q4
2 quarters
|
|
1819
Real REMAX Group Inc. Common Stock
REAX
$336M
| $27K | ﹤0.01% |
1,485
+284
| +24% | +$5.77K |
2025 Q4
2 quarters
|
|
1820
Vista Gold
VGZ
$400M
| $26.2K | ﹤0.01% |
+13,727
| New | +$29.9K |
2026 Q2
0 quarters
|
|
1821
OmniAb
OABI
$683M
| $25.8K | ﹤0.01% |
+10,472
| New | +$20.8K |
2026 Q2
0 quarters
|
|
1822
EVgo
EVGO
$150M
| $24.8K | ﹤0.01% |
12,973
+1,470
| +13% | +$2.96K |
2026 Q1
1 quarter
|
|
1823
enCore Energy
EU
$156M
| $24.3K | ﹤0.01% |
18,567
+2,000
| +12% | +$3.36K |
2024 Q2
8 quarters
|
|
1824
Microvast
MVST
$196M
| $23.8K | ﹤0.01% |
20,305
+2,185
| +12% | +$3.37K |
2025 Q2
4 quarters
|
|
1825
Inhibikase Therapeutics
IKT
$229M
| $23.4K | ﹤0.01% |
+11,550
| New | +$20.7K |
2026 Q2
0 quarters
|
|
Similar funds
NMO
Xponance's Q2 2026 Portfolio in Review
As of Q2 2026, Xponance held 1,883 positions worth $16.3B, up 16% from $14.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Xponance's Q2 2026 filing shows 197 new, 1,009 increased, 634 reduced and 42 closed positions. Its largest new stake was SpaceX: 114,259 shares worth $19.5M. The largest sale was Apple, an estimated $149M.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 36% a quarter earlier, followed by Communication Services and Financials.
- Xponance's largest Q2 2026 buy was SpaceX: 114,259 shares worth $19.5M.
- Xponance added most to Micron Technology in Q2 2026, an estimated $80.6M increase.
- Xponance's biggest Q2 2026 reduction was Apple, cutting an estimated $149M.
- Xponance fully exited Coterra Energy in Q2 2026, selling an estimated $4.27M.
- Xponance's ten largest holdings make up 37% of its $16.3B portfolio in Q2 2026.
- Xponance opened 197 new positions and closed 42 in Q2 2026.
- Xponance's portfolio value rose 16% quarter-over-quarter to $16.3B.
Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.